Schrödinger, Inc., a company renowned for its computational software in drug discovery, has navigated the biotech landscape for 35 years while traditionally refraining from associating its platform with artificial intelligence (AI). This distinct approach has set Schrödinger apart from pure
Bispecific antibodies (BsAbs) are reshaping targeted therapies with their unique ability to engage two distinct targets simultaneously. This breakthrough innovation significantly diverges from traditional monospecific monoclonal antibodies (mAbs), opening up new avenues for treating various
James Maitland is an expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. How is the pharmaceutical industry undergoing digital transformation? What role is cloud computing playing in this transformation? The
James Maitland is an esteemed expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. In this interview, we delve into his extensive research and contributions to liver fibrosis. We will cover his background,
How Has Antimicrobial Resistance of S. aureus Evolved in Chinese PICUs? The landscape of antimicrobial resistance (AMR) is constantly evolving, and this is particularly true for Staphylococcus aureus in pediatric intensive care units (PICUs) across China. Over the past several years, the prevalence
Artificial Intelligence (AI) is rapidly gaining momentum in the pharmaceutical industry, with healthcare professionals (HCPs) expressing enthusiastic optimism about its potential to revolutionize various aspects of healthcare, from drug discovery and diagnostics to patient care. This enthusiasm is
